» Articles » PMID: 15690031

Regulation of Cap-dependent Translation by EIF4E Inhibitory Proteins

Overview
Journal Nature
Specialty Science
Date 2005 Feb 4
PMID 15690031
Citations 469
Authors
Affiliations
Soon will be listed here.
Abstract

Eukaryotic messenger RNAs contain a modified guanosine, termed a cap, at their 5' ends. Translation of mRNAs requires the binding of an initiation factor, eIF4E, to the cap structure. Here, we describe a family of proteins that through a shared sequence regulate cap-dependent translation. The biological importance of this translational regulation is immense, and affects such processes as cell growth, development, oncogenic transformation and perhaps even axon pathfinding and memory consolidation.

Citing Articles

RNA-binding proteins as therapeutic targets in cancer.

Jungfleisch J, Gebauer F RNA Biol. 2025; 22(1):1-8.

PMID: 40016176 PMC: 11869776. DOI: 10.1080/15476286.2025.2470511.


Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows.

Medici B, Caffari E, Maculan Y, Benatti S, Piacentini F, Dominici M Biomedicines. 2025; 13(2).

PMID: 40002868 PMC: 11853220. DOI: 10.3390/biomedicines13020455.


Canine parvovirus NS1 induces host translation shutoff by reducing mTOR phosphorylation.

Wang X, Hao X, Zhao Y, Xiao X, Li S, Zhou P J Virol. 2024; 99(1):e0146324.

PMID: 39601560 PMC: 11784071. DOI: 10.1128/jvi.01463-24.


Post-transcriptional regulation of and mRNAs is mediated by Bruno 1 and Cup, and further fine-tuned within P-bodies.

Bayer L, Milano S, Kaur H, Bratu D bioRxiv. 2024; .

PMID: 39464095 PMC: 11507948. DOI: 10.1101/2024.10.17.618951.


Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets.

Sehrawat U Int J Mol Sci. 2024; 25(19).

PMID: 39409166 PMC: 11477148. DOI: 10.3390/ijms251910835.